- 2014
-
Press releases - 04.07.2014
Laser bioprinting in Bordeaux : an innovative approach
One of the goals of the laboratory is to develop laser and microfabrication technologies with the aim of printing tissues in vitro and in vivo. The researchers in the laboratory were pioneers in Europe, developing laser-assisted bioprinting from 2005. This Inserm/University of Bordeaux joint research unit is one of a very few worldwide to use this process. The objective of Fabien Guillemot’s team is therefore not only to position cells in 3D, but to define and model the self-assembly dynamic of the printed cells.
-
News in brief - 02.07.2014
New risk factors for alcohol abuse in adolescents brought to light
An international team involving researchers from INSERM, CEA and APHP in France have successfully modelled the risk factors for alcohol abuse during adolescence. The results of the study were published on Nature Magazine’s website on 2 July. In France, alcohol consumption most often begins in adolescence. Today, 80% of 17-year-olds admit to having consumed alcohol […]
-
Press releases - 30.06.2014
Alzheimer’s disease: simplified diagnosis, with more reliable criteria
How many patients receive an incorrect diagnosis of Alzheimer’s disease? The answer is a surprisingly high number: over a third! To reduce the number of errors, the diagnostic criteria must be the most reliable possible, especially at the very early stages of the disease. For the last decade, an international team of neurologists, coordinated by Bruno Dubois (Inserm/Pierre and Marie Curie University/AP-HP Joint Research Unit 975) has been working towards this. In the June issue of The Lancet Neurology journal, we see how the researchers have developed a simplified diagnosis based on the most specific criteria of the disease. A challenge primarily for research, but also for clinical practice.
-
Press releases - 25.06.2014
Neurons are oversensitive to cellular stress from the outset in Huntington’s disease
Neurons cannot properly defend themselves against Huntington’s disease, right from the onset of the pathology. This has been discovered by a team of Inserm researchers from the Paris-Seine Biology Institute (IBPS) (Inserm/CNRS/Pierre and Marie Curie University) and their American and Australian colleagues. The cause is the failure of an important mechanism involved in cellular longevity. In addition to this result, the present study shows the importance of restoring the ability of the neurons to resist stress in order to delay the manifestations of the disease. This work is leading to a new approach for treating neurodegenerative diseases. The results of this work are published in PLoS Biology.
-
What's on? - 23.06.2014
New outbreak of ebola fever in Africa
According to WHO, between 29 May and 1 June 2014, 37 new cases of Ebola fever and 21 deaths were recorded in Guinea, and 13 new cases (no deaths) were recorded in Liberia. The Jean Mérieux BSL-4 Laboratory is a high-level containment laboratory dedicated to the study of class 4 pathogens. The biological safety level applied is 4, […]
-
Press releases - 20.06.2014
How a stem cell sees red
Many medical situations require a supply of red blood cells—anaemia, road accidents and chemotherapy, for example. But there is a genuine shortage of blood. Researchers throughout the world are therefore working hard to find solutions to alleviate these shortages, and their sights are set on the potential for creating an unlimited supply of red blood […]
-
Press releases - 19.06.2014
Can injuries to the skin be painless?
Teams led by Priscille Brodin in Lille and Laurent Marsollier in Angers have studied lesions in patients with Buruli ulcer, a tropical disease.
-
What's on? - 18.06.2014
2014 World Sickle Cell Awareness Day
Thursday 19 June 2014 is World Sickle Cell Disease Day. This is the most widespread genetic disorder in the world: It affects over five million people(1). It can have serious consequences—anaemia, episodes of pain—and may involve different organs or reduced resistance to certain infections. From the physiological point of view, this disease of the blood […]
-
Press releases - 17.06.2014
The Inserm Ethics Committee publishes two notes on embryo research and gender research
A l’occasion de leur première grande réunion annuelle, qui a eu lieu ce mardi 17 juin à l’Auditorium de l’Hôpital Européen Georges Pompidou, plusieurs groupes de travail du Comité d’éthique de l’Inserm dont le groupe « Embryon & développement » et le groupe « Genre et recherche en santé » rendent leur avis sous forme de note.
-
Press releases - 13.06.2014
H1N1 influenza: Vaccination induces an immune memory response comparable to that of a moderate infection
How long does the immune memory response produced by vaccination last? Is it similar to that induced by the infection itself? New information on the A(H1N1) pandemic influenza virus has just been brought to light by researchers at Joint Research Unit 1135, Cimi-Paris (Centre for Immunology and Infectious Diseases – Inserm – Pierre and Marie Curie University).